BRCA1 and ovarian carcinoma: In the literature, two randomized controlled trials evaluating patient decision aids for women at increased risk of ovarian cancer only included RRSO and ovarian screening as options and were developed more than 10 years ago.15, 16 Patient decision aids about RRSO in BRCA1/2 mutation carriers do not exist in Dutch.